To further explore the mechanisms behind the synergistic effect of p300 activation combined with DA treatment for pituitary adenomas, we hypothesized that acetylation at H3K18/27, mediated by the p300 HAT domain, plays a critical role in regulating DRD2 transcription. The gene discussed is EP300; the disease is pituitary gland adenoma.